PDCD1 and cancer: Inhibitory ligands, such as programmed death-ligand 1 (PD-L1) expressed on cancer cells, bind to the corresponding inhibitory receptor, programmed cell death protein 1 (PD-1), expressed on T cells, leading to inhibition of T cell activation signals (Boussiotis, 2016; Wong S. H. D. et al., 2021).